This study aimed to evaluate and compare an easy and feasible, index-lesion-based SPECT dosimetry method with mean tumor doses in multiple tumor lesions on a patient level and to correlate dosimetry data with clinical outcome after 177Lu-PSMA RLT. Here, FOLH1 is linked to neoplasm.